About Osprey Pharmaceuticals USA
Osprey Pharmaceuticals USA is a company based in San Francisco (United States) founded in 1998. It operates as a B2B. Osprey Pharmaceuticals USA has raised $14.89 million across 3 funding rounds from investors including Novo Nordisk, BDC and Western Technology Investment. Osprey Pharmaceuticals USA operates in a competitive market with competitors including Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics, Alpine Immune Sciences and Septerna, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.89 M (USD)
in 3 rounds
-
Latest Funding Round
$5.89 M (USD), Series A
May 18, 2009
-
Investors
Novo Nordisk
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Osprey Pharmaceuticals USA
Osprey Pharmaceuticals USA has successfully raised a total of $14.89M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.89 million completed in May 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $5.9M
-
First Round
First Round
(30 Jan 2007)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2009 | Amount | Series A - Osprey Pharmaceuticals USA | Valuation |
investors |
|
| Jan, 2007 | Amount | Debt – Venture - Osprey Pharmaceuticals USA | Valuation |
investors |
|
| Jan, 2007 | Amount | Series A - Osprey Pharmaceuticals USA | Valuation | Burrill and Company |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Osprey Pharmaceuticals USA
Osprey Pharmaceuticals USA has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Novo Nordisk, BDC and Western Technology Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Osprey Pharmaceuticals USA
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Osprey Pharmaceuticals USA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Osprey Pharmaceuticals Usa Comparisons
Competitors of Osprey Pharmaceuticals USA
Osprey Pharmaceuticals USA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics, Alpine Immune Sciences and Septerna, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
|
| domain | founded_year | HQ Location |
GPCR drug discovery platform is developed for multiple diseases.
|
|
| domain | founded_year | HQ Location |
CRAC channel inhibitors are developed for inflammatory diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Osprey Pharmaceuticals Usa
Frequently Asked Questions about Osprey Pharmaceuticals USA
When was Osprey Pharmaceuticals USA founded?
Osprey Pharmaceuticals USA was founded in 1998 and raised its 1st funding round 9 years after it was founded.
Where is Osprey Pharmaceuticals USA located?
Osprey Pharmaceuticals USA is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Osprey Pharmaceuticals USA a funded company?
Osprey Pharmaceuticals USA is a funded company, having raised a total of $14.89M across 3 funding rounds to date. The company's 1st funding round was a Debt – Venture of $3M, raised on Jan 30, 2007.
What does Osprey Pharmaceuticals USA do?
Osprey Pharmaceuticals USA, based in San Francisco, focuses on providing healthcare solutions, producing pharmaceutical products, medication development, and immune disease treatments. Specializes in medications for inflammatory and immune-related diseases. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Who are the top competitors of Osprey Pharmaceuticals USA?
Osprey Pharmaceuticals USA's top competitors include Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences.
Who are Osprey Pharmaceuticals USA's investors?
Osprey Pharmaceuticals USA has 7 investors. Key investors include Novo Nordisk, BDC, Western Technology Investment, Burrill and Company, and MMV Financial.